News

Pharmaceutical Technology on MSN2d
Valneva’s chikungunya vaccine use halted in older adults amid safety concerns
Both the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...
2VALN : US Health Agencies Recommend Pausing Valneva's Chikungunya Vaccine For...
FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...
U.S. Advises Older Travelers to Avoid Chikungunya Vaccine
TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...
US health officials advise older travelers not to get a chikungunya vaccine
The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...
CIDRAP2d
FDA, CDC recommend pause in Valneva chikungunya vaccine for older adults
In a statement today, the company said it supports recent precautionary measures and that thorough investigations are needed ...
Europe reviews Valneva's chikungunya vaccine after reports of serious side effects
The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after ...
BioPharma Dive2d
FDA follows EMA in limiting use of Valneva shot
Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...
Feds recommend pausing vaccine for mosquito-borne disease chikungunya in people over 60
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...